6th Annual MarketsandMarkets

Biomarker and Companion Diagnostics Conference

13th - 14th March 2025

London, UK

“Empowering Precision Medicine: Navigating Regulatory Landscapes & Innovating Biomarker Solutions”

The maturing regulatory landscape for companion diagnostics and IVD in the UK and Europe, along with new technologies like AI/ML, next-generation sequencing, and genetic-based diagnostics, has brought us to a pivotal point where personalized medicines for all patients are within reach. Join us at the 6th Annual Biomarker and Companion Diagnostics Conference, scheduled for March 13th-14th, 2025, in London, UK.

The 2025 programme will delve into the intricacies of navigating regulatory barriers with a specific focus on companion diagnostics (CdX) and the complexities of biomarkers. Come together on this dynamic platform where we foster collaboration, share knowledge, and explore cutting-edge research and applications. Esteemed keynote speakers will provide groundbreaking insights into the latest developments and future prospects of biomarker research, fostering collaboration and driving innovation in the field of companion diagnostics.

Anticipated as one of the most prominent industry-led meetings, this conference unites over 200 senior decision-makers in the biomarker and CDx fields, offering unparalleled insights. Attendees will gain practical knowledge to identify advancements in Translational Medicine and Precision Medicine development across both oncology and non-oncology indications encompassing modalities such as gene therapy and protein degradation, and novel biomarkers such as cfDNA and circulating histones, among many others.

Join us in exploring these transformative subjects and advancing the future of personalized medicine.


  • Biomarker Discovery Techniques: Explore novel strategies, including genomics, proteomics, metabolomics, and bioinformatics, to identify cutting-edge biomarkers.
  • Precision Medicine Tailoring: Understand the pivotal role of biomarkers in customizing treatments for individual patients, enhancing efficacy, and minimizing side effects.
  • Rigorous Biomarker Validation: Learn strategies and overcome challenges in validating biomarkers for clinical use, ensuring robust and reliable results.
  • Clinical Applications Across Disorders: Delve into biomarker applications in cancer, immunology, neurodegenerative disorders, and cardiovascular conditions for targeted advancements.
  • Bioinformatics and AI Analysis: Attend workshops and sessions on biomarker data analysis, employing machine learning and artificial intelligence approaches for comprehensive insights.
  • Biomarker-Based Diagnostics Development: Gain insights into the development and commercialization of diagnostic tests and platforms based on biomarkers.
  • Regulatory Frameworks for CDx: Stay updated on current regulatory frameworks for CDx development, facilitating smoother approvals and applications.
  • Expanding Biomarker Testing Access: Navigate reimbursement landscapes through cross-sector collaborations to widen access to biomarker testing.
  • Innovative Strategies in CDx Development: Implement new CDx strategies to bring innovative therapies to the clinic, ensuring effective market access in line with global trends.
  • Collaboration for Advancement: Explore sessions on fostering collaboration among academia, industry, and government agencies to drive biomarker research forward.

  • Cutting-Edge Insights: Access the latest advancements in biomarker discovery, precision medicine, and clinical applications spanning cancer, immunology, neurodegenerative disorders, and cardiovascular biomarkers.
  • Innovative Immunotherapy: Dive into immune-oncology projects, exploring antibodies, cellular therapy, and immune checkpoint research. Contribute to interactive discussions, share your work, and stay updated on cutting-edge technologies and platforms.
  • Networking and Collaboration: Connect with industry leaders, researchers, and peers. Foster collaborations, engage in thought-provoking discussions, and explore partnership opportunities.
  • Professional Development: Enhance your skills with workshops on biomarker data analysis, machine learning, and artificial intelligence applications. Learn best practices and methodologies for biomarker and IO research.
  • Practical Applications: Discover how research translates into real-world applications. Explore exhibitor showcases, demonstrations, and case studies, gaining insights into the latest tools and technologies.
  • Personal and Industry Growth: Step out of your comfort zone, engage in interactive roundtables, and contribute to key discussions. Elevate your personal and professional growth within the dynamic fields of biomarker research and immunotherapy.
  • Engage in groundbreaking research, expand your network, and drive innovation at the Immunobio Series, where science meets collaboration.

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Pathology
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Cell & Gene therapy markers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
  • Immuno-oncology/Neuroscience Drug Discovery
  • Diagnostic Biomarkers development
  • Personalized Medicine
  • Immunology Biomarkers




London, UK